Header cover image

Pharmaceuticals & Biotech Consumer Discretionary

Results

1272

0 new

All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.

1,272 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ELTP

Elite Pharmaceuticals
US$0.394.2%315.8%US$416.6mn/aPE21.3xn/an/a

NWBO

Northwest Biotherapeutics
US$0.33-2.5%-64.7%US$413.8mn/aPS251.6xn/an/a

CCCC

C4 Therapeutics
US$5.89-4.5%246.5%US$408.4mUS$15.00PS13.9xE3.6%n/a

FATE

Fate Therapeutics
US$3.57-1.9%85.9%US$406.5mUS$6.46PS33xE-9.3%n/a

RNAC

Cartesian Therapeutics
US$17.0014.3%n/aUS$406.2mUS$41.60PS7.5xE5.9%n/a

EBS

Emergent BioSolutions
US$7.4923.6%137.0%US$404.6mUS$8.00PB1xE106.4%n/a

PRME

Prime Medicine
US$3.46-3.9%-60.4%US$402.4mUS$13.45PS680.9xE-3.2%n/a

TBPH

Theravance Biopharma
US$8.102.0%-6.7%US$396.3mUS$13.20PS6.4xE57.2%n/a

SLGC

Standard BioTools
US$2.10-14.3%-28.1%US$396.2mUS$3.93PS4.8xE8.1%n/a

CYRX

Cryoport
US$8.00-0.1%-39.1%US$395.3mUS$12.56PS1.8xE57.2%n/a

LYEL

Lyell Immunopharma
US$1.515.6%5.6%US$386.6mUS$3.67PS7158.6xE-14.8%n/a

ITOS

iTeos Therapeutics
US$10.50-0.9%0.9%US$383.5mUS$34.83PS11xE3.8%n/a

ORGO

Organogenesis Holdings
US$2.892.5%-2.7%US$383.1mUS$4.38PB1.5xE82.8%n/a

ORTX

Orchard Therapeutics
US$16.700.9%188.9%US$380.1mUS$16.00PS17.4xE12.5%n/a

ACIU

AC Immune
US$3.752.5%32.0%US$371.0mUS$10.30PS20.1xE55.3%n/a

NAUT

Nautilus Biotechnology
US$2.914.5%-1.4%US$364.9mUS$4.13PB1.6xE-9.2%n/a

ZVRA

Zevra Therapeutics
US$6.92-14.1%43.6%US$364.1mUS$20.50PS15.4xE68.5%n/a

ANIK

Anika Therapeutics
US$24.56-1.8%31.4%US$363.4mUS$34.50PS2.2xE121.6%n/a

BMEA

Biomea Fusion
US$9.9020.0%-22.1%US$358.5mUS$30.22PB3.4xE8.9%n/a

GHRS

GH Research
US$6.88-1.6%-33.3%US$358.0mUS$32.00PB1.8xE-26.7%n/a

CAPR

Capricor Therapeutics
US$9.9566.7%235.0%US$351.6mUS$31.00PS12.9xE68.7%n/a

ARTV

Artiva Biotherapeutics
US$14.0111.6%n/aUS$340.3mUS$21.25PS11.6xE-24.6%n/a

CINV

Crucial Innovations
US$4.550%n/aUS$338.6mn/an/an/an/a

ELYM

Eliem Therapeutics
US$4.98-34.7%91.5%US$334.0mn/aPB1.5xn/an/a
Page 14 of 53
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.